A new study uses DNA origami ... A Repurposed Anti-Inflammatory Drug May Help Treat Alcohol Use Disorder and Related Pain Apr. 22, 2025 — A preclinical study finds that a drug already FDA ...

Receptor pharmacology is the study of the interactions of receptors with drugs/pharmaceuticals and other xenobiotics. A basic tenet of receptor pharmacology is that a drug’s effect is directly ...

[15] Another two interesting studies are reported in the review by Flora et al. [71] The first study was performed in 2637 patients with chronic liver disease, treated with high doses of silymarin ...

A recent study finds that deep regional disparities persist, although the global asthma burden has declined significantly over the past three decades.

Remedium Lifecare Limited has announced the strategic objectives of its upcoming rights issue, recently approved by the ...

Our courses cover the full breadth of biology, from molecular and cell biology, genetics, development, human physiology and pharmacology through to evolution ... Barbaric convened to address the risks ...

Now, results from a new study of adolescents in the US suggest ... Sign up to get the BEST of Tom's Guide direct to your inbox. Get instant access to breaking news, the hottest reviews, great ...

THURSDAY, April 24, 2025 (HealthDay News) — Patients who legitimately need opioid painkillers are finding it more difficult ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

June 12, 2023 — Women who used combined contraceptive pills were at greater risk of developing depression than women who did not, according to a new study. Contraceptive pills increased women's ...

A forthcoming rewrite to this guide will recommend the Thermacell E65 ... Photo: Doug Mahoney A study in Acta Tropica looked at three different traps and found that they “either significantly ...

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of chronic kidney disease.